IMMUNOVENT
Founded by NYC biotech scientists and entrepreneurs, Immunovent, LLC is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented LAMB-Dx test. The Local Allergy Mucosal Brush (LAMB-Dx) test detects small amounts of antigen-specific IgE from symptomatic areas of the body, such as the mouth and the nose. Through a gentle and easy mucosal brush sampling procedure and a proprietary diagnostic assay, LAMB-Dx rapidly and safely diagnoses common allergies without the inconveniences and issues of conventional skin prick and blood testing.
IMMUNOVENT
Industry:
Health Care
Founded:
2013-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.immunovent.com
Total Employee:
1+
Status:
Active
Contact:
6464948432
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network GoDaddy DNS Typekit GoDaddy Email Squarespace Squarespace Hosted FullStory
Similar Organizations
In-Line Diagnostics
In-Line Diagnostics.
Protean BioDiganostics Inc
Precision Oncology and Diagnostics
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.immunovent.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Immunovent"
Immunovent
Founded by NYC biotech scientists and entrepreneurs, Immunovent, LLC is revolutionizing allergy diagnostics by coupling existing clinical practices with our patented LAMB-Dx test. The Local …See details»
About - Immunovent
Currently, Immunovent is optimizing the protocols for patient sample collection, preparation, processing, and testing at a New York City-based biomedical research center and at our laboratory located in the Harlem Biospace. We …See details»
Immunovent - Crunchbase Company Profile & Funding
Founded by NYC biotech scientists and entrepreneurs, Immunovent, LLC is revolutionizing allergy diagnostics by coupling existing clinical practices with their patented LAMB-Dx test. The Local Allergy Mucosal Brush (LAMB-Dx) test …See details»
Team - Immunovent
Our Team. Combines the Best in Biotech and Business. About; Introduction; LAMB-Dx; Team; Tom Cirrito, PhD. Chief Executive Officer & InventorSee details»
Immunovent Company Profile | Management and Employees List
Immunovent Profile and History Immunovent is a NYC-based bioventure that is focusing on the commercialization of novel technologies for diagnosing allergies. The company is currently …See details»
Immunovent, LLC - Company Profile & Staff Directory - ContactOut
Founded by NYC biotech scientists and entrepreneurs, Immunovent, LLC is revolutionizing allergy diagnostics by coupling existing clinical practices with our patented LAMB-Dx test. The Local …See details»
Immunovent, LLC - LinkedIn
Immunovent, LLC | 149 followers on LinkedIn. Founded by NYC biotech scientists and entrepreneurs, Immunovent, LLC is revolutionizing allergy diagnostics by coupling existing …See details»
Immunovent - Overview, News & Similar companies | ZoomInfo.com
Immunovent is a NYC-based bioventure that is focusing on the commercialization of novel technologies for diagnosing allergies. The company is currently developing the Local Antibody …See details»
Immunovent, LLC | VentureRadar
Immunovent, LLC is focused on the commercialization of next-generation technologies for allergy diagnosis. The company is developing the Local Allergy Mucosal Brush Test (LAMB-Dx), the …See details»
Immunovent - Company Profile - Tracxn
Nov 17, 2024 Immunovent develops diagnostics tests for allergies. Its Local Antibody Mucosal Brush Diagnostic (LAMB-Dx) test uses a proprietary assay to detect IgE immunoglobulins in a …See details»
Immunovent - Products, Competitors, Financials, Employees, …
Immunovent is a biotechnology company that focuses on allergy diagnostics within the healthcare sector. The company offers the LAMB-Dx test, which is a diagnostic tool that detects small …See details»
Immunovent: Revenue, Competitors, Alternatives - growjo.com
What Is Immunovent? Founded by NYC biotech scientists and entrepreneurs, Immunovent, LLC is revolutionizing allergy diagnostics by coupling existing clinical practices with our patented …See details»
Introduction — Immunovent
Over $1.2 billion is spent on annual allergy testing, but up to 20% of people with allergy symptoms are misdiagnosed. Why? - We're Looking at the Wrong Areas Rather than focusing on …See details»
Immunovent - Contacts, Employees, Board Members, Advisors
Organization. Immunovent . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. ... Immunovent has 1 board …See details»
Immunovent Company Profile -Sales, Contacts, Competitors – …
Immunovent is in the In Vitro Diagnostics industry within the Chemicals and Allied Products sector and has been in business for approximately 10 years. The Most Advanced Company …See details»
Immunovant, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Nov 1, 2024 The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase …See details»
Immunovent, LLC - Center For Technology Licensing
Mar 20, 2018 Immunovent, LLC is focused on the commercialization of next-generation technologies for allergy diagnosis. The company is developing the Local Allergy Mucosal …See details»
Immunovant - Crunchbase Company Profile & Funding
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Its investigational product candidate, IMVT-1401 (formerly …See details»
Newsroom — Immunovent
Exciting News Straight from Immunovent. Press Releases. Outside Perspectives on Immunovent's InnovationsSee details»
Immunovant shares surge as early antibody treatment data beats …
Sep 26, 2023 (Reuters) -Shares of Immunovant more than doubled on Tuesday after early-stage data from its experimental antibody treatment exceeded analysts' expectations. The drug …See details»